Cargando…

Retraction Note: Genomic amplification and high expression of EGFR are key targetable oncogenic events in malignant peripheral nerve sheath tumor

Detalles Bibliográficos
Autores principales: Du, Xiaoling, Yang, Jilong, Ylipää, Antti, Zhu, Ze
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9608896/
https://www.ncbi.nlm.nih.gov/pubmed/36303190
http://dx.doi.org/10.1186/s13045-022-01380-7
_version_ 1784818879920340992
author Du, Xiaoling
Yang, Jilong
Ylipää, Antti
Zhu, Ze
author_facet Du, Xiaoling
Yang, Jilong
Ylipää, Antti
Zhu, Ze
author_sort Du, Xiaoling
collection PubMed
description
format Online
Article
Text
id pubmed-9608896
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-96088962022-10-28 Retraction Note: Genomic amplification and high expression of EGFR are key targetable oncogenic events in malignant peripheral nerve sheath tumor Du, Xiaoling Yang, Jilong Ylipää, Antti Zhu, Ze J Hematol Oncol Retraction Note BioMed Central 2022-10-27 /pmc/articles/PMC9608896/ /pubmed/36303190 http://dx.doi.org/10.1186/s13045-022-01380-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Retraction Note
Du, Xiaoling
Yang, Jilong
Ylipää, Antti
Zhu, Ze
Retraction Note: Genomic amplification and high expression of EGFR are key targetable oncogenic events in malignant peripheral nerve sheath tumor
title Retraction Note: Genomic amplification and high expression of EGFR are key targetable oncogenic events in malignant peripheral nerve sheath tumor
title_full Retraction Note: Genomic amplification and high expression of EGFR are key targetable oncogenic events in malignant peripheral nerve sheath tumor
title_fullStr Retraction Note: Genomic amplification and high expression of EGFR are key targetable oncogenic events in malignant peripheral nerve sheath tumor
title_full_unstemmed Retraction Note: Genomic amplification and high expression of EGFR are key targetable oncogenic events in malignant peripheral nerve sheath tumor
title_short Retraction Note: Genomic amplification and high expression of EGFR are key targetable oncogenic events in malignant peripheral nerve sheath tumor
title_sort retraction note: genomic amplification and high expression of egfr are key targetable oncogenic events in malignant peripheral nerve sheath tumor
topic Retraction Note
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9608896/
https://www.ncbi.nlm.nih.gov/pubmed/36303190
http://dx.doi.org/10.1186/s13045-022-01380-7
work_keys_str_mv AT duxiaoling retractionnotegenomicamplificationandhighexpressionofegfrarekeytargetableoncogeniceventsinmalignantperipheralnervesheathtumor
AT yangjilong retractionnotegenomicamplificationandhighexpressionofegfrarekeytargetableoncogeniceventsinmalignantperipheralnervesheathtumor
AT ylipaaantti retractionnotegenomicamplificationandhighexpressionofegfrarekeytargetableoncogeniceventsinmalignantperipheralnervesheathtumor
AT zhuze retractionnotegenomicamplificationandhighexpressionofegfrarekeytargetableoncogeniceventsinmalignantperipheralnervesheathtumor